<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; North America</title>
	<atom:link href="http://www.bioscreening.net/category/news-by-region/north-america/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Natural compounds derived from plants could yield hundreds of new drugs</title>
		<link>http://www.bioscreening.net/2011/12/22/natural-compounds-derived-from-plants-could-yield-hundreds-of-new-drugs/</link>
		<comments>http://www.bioscreening.net/2011/12/22/natural-compounds-derived-from-plants-could-yield-hundreds-of-new-drugs/#comments</comments>
		<pubDate>Thu, 22 Dec 2011 08:10:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1367</guid>
		<description><![CDATA[NYBG scientist says the plant world has &#8220;great potential&#8221; as a source of new medicines There are probably at least 500 medically useful chemicals awaiting discovery in plant species whose chemical constituents have not yet been evaluated for their potential to cure or treat disease, according to a new analysis by a New York Botanical [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/12/22/natural-compounds-derived-from-plants-could-yield-hundreds-of-new-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NMR Fine-Tuned for High-Content Metabolomics Screening</title>
		<link>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/</link>
		<comments>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 17:48:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1350</guid>
		<description><![CDATA[Scientists report on the development of a nuclear magnetic resonance (NMR)-based method forscreening the metabolomic response of drug-treated mammalian cells to drug therapy. TheSanford-Burnham Medical Research Institute, and Rady Children’s Hospital investigators, say the highly sensitive, fast, and simple method is carried out in 96-well format, and could have particular utility as a method for high-throughput [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Research at A&amp;M and Scripps finds HIV-killing compound</title>
		<link>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/</link>
		<comments>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 17:35:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1348</guid>
		<description><![CDATA[COLLEGE STATION - A powerful topical preventative for HIV, the virus that causes AIDS, could be a step closer to clinical trials, thanks to a newly discovered molecular compound that research at Texas A&#38;M University and the Scripps Research Institute shows dissolves the virus on contact. The ability of the synthetic compound known as &#8220;PD 404,182&#8243; [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ancient Chinese cures translate into modern Western medicines</title>
		<link>http://www.bioscreening.net/2011/11/28/ancient-chinese-cures-translate-into-modern-western-medicines/</link>
		<comments>http://www.bioscreening.net/2011/11/28/ancient-chinese-cures-translate-into-modern-western-medicines/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 14:45:27 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1357</guid>
		<description><![CDATA[The Chem-TCM is the most comprehensive database of its kind and translates more than 12,000 chemicals from more than 300 Chinese herbs used in traditional Chinese medicine (TCM) into Western terminology. &#8220;Future researchers will now be able to better understand the chemical basis of remedies that have been in use for thousands of years,&#8221; says [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/ancient-chinese-cures-translate-into-modern-western-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccine for ovarian, breast cancer shows promise</title>
		<link>http://www.bioscreening.net/2011/11/09/vaccine-for-ovarian-breast-cancer-shows-promise/</link>
		<comments>http://www.bioscreening.net/2011/11/09/vaccine-for-ovarian-breast-cancer-shows-promise/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 18:40:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1312</guid>
		<description><![CDATA[(CBS) A new vaccine that targets ovarian and breast cancer has shown promise in early studies, giving scientists hope they may be closer to stopping the deadly diseases. PICTURES: 25 breast cancer myths busted Known as PANVAC, the vaccine triggers the immune system to attack tumor cells. &#8220;With this vaccine, we can clearly generate immune [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/09/vaccine-for-ovarian-breast-cancer-shows-promise/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study: Shark Chemical May Protect Humans Against Viruses</title>
		<link>http://www.bioscreening.net/2011/09/20/study-shark-chemical-may-protect-humans-against-viruses/</link>
		<comments>http://www.bioscreening.net/2011/09/20/study-shark-chemical-may-protect-humans-against-viruses/#comments</comments>
		<pubDate>Tue, 20 Sep 2011 17:19:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1296</guid>
		<description><![CDATA[A chemical derived from sharks could help protect humans against viral infections such as hepatitis, American research out Tuesday showed. Scientists found that a chemical called squalamine demonstrated effective antiviral activity against a range of human viruses from yellow fever to hepatitis B, C and D, in both lab and animal experiments. As the chemical [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/20/study-shark-chemical-may-protect-humans-against-viruses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Canadian-made virus shows promise as cancer treatment</title>
		<link>http://www.bioscreening.net/2011/08/31/canadian-made-virus-shows-promise-as-cancer-treatment/</link>
		<comments>http://www.bioscreening.net/2011/08/31/canadian-made-virus-shows-promise-as-cancer-treatment/#comments</comments>
		<pubDate>Wed, 31 Aug 2011 20:32:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1272</guid>
		<description><![CDATA[An Ottawa-based research team has developed a virus that is showing promise as a new way of attacking and shrinking cancer tumours while leaving healthy tissue alone. It&#8217;s early days in the still-experimental field of therapeutic cancer viruses, called oncolytic viruses. But this new study from researchers from the Ottawa Hospital Research Institute (OHRI) and the [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/31/canadian-made-virus-shows-promise-as-cancer-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic Link Predisposes to Mesothelioma</title>
		<link>http://www.bioscreening.net/2011/08/29/genetic-link-predisposes-to-mesothelioma/</link>
		<comments>http://www.bioscreening.net/2011/08/29/genetic-link-predisposes-to-mesothelioma/#comments</comments>
		<pubDate>Mon, 29 Aug 2011 15:34:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1269</guid>
		<description><![CDATA[An investigation led by scientists at the University of Hawaii Cancer Center, Honolulu, and Fox Chase Cancer Center, Philadelphia has identified germline mutations in the BAP1 gene that predispose individuals to malignant mesothelioma. The research, published online yesterday in Nature Genetics, describes two U.S. families with a high incidence of mesothelioma, as well as other [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/29/genetic-link-predisposes-to-mesothelioma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New tests screen for gum disease, oral cancer</title>
		<link>http://www.bioscreening.net/2011/08/10/new-tests-screen-for-gum-disease-oral-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/10/new-tests-screen-for-gum-disease-oral-cancer/#comments</comments>
		<pubDate>Wed, 10 Aug 2011 15:10:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1242</guid>
		<description><![CDATA[Future dental visits may involve more than a simple cleaning. Oral DNA testing may also help screen patients for gum disease or oral cancer. Dr. Jessica Lawson of Urbandale Family Dentistry began offering the tests last spring. Two tests involve gum disease and a third for oral human papillomavirus, or HPV, assesses risks for oral [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/10/new-tests-screen-for-gum-disease-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urine Test May Help Detect, Stratify Prostate Cancer</title>
		<link>http://www.bioscreening.net/2011/08/04/urine-test-may-help-detect-stratify-prostate-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/04/urine-test-may-help-detect-stratify-prostate-cancer/#comments</comments>
		<pubDate>Thu, 04 Aug 2011 15:07:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1235</guid>
		<description><![CDATA[In men with elevated prostate specific antigen (PSA), an investigational urine test can detect and stratify prostate cancer, researchers reported. The test is based on the detection of a gene fusion that is specific to prostate cancer, combined with another marker, according to Arul Chinnaiyan, MD, PhD, of the University of Michigan Medical School in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/04/urine-test-may-help-detect-stratify-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Claim Leukemia Stem Cell Signature Independently Predicts Poor Survival in AML</title>
		<link>http://www.bioscreening.net/2011/08/02/scientists-claim-leukemia-stem-cell-signature-independently-predicts-poor-survival-in-aml/</link>
		<comments>http://www.bioscreening.net/2011/08/02/scientists-claim-leukemia-stem-cell-signature-independently-predicts-poor-survival-in-aml/#comments</comments>
		<pubDate>Tue, 02 Aug 2011 15:27:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1276</guid>
		<description><![CDATA[Research on samples from human acute myeloid leukemia (AML) patients has suggested that the a leukemia stem cell (LSC) gene expression profile can accurately be used to predict patient survival, even among AML patients with cytogenetically normal disease. An international team led by researchers at Ontario’s University Health Network and the University of Toronto’s Department [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/02/scientists-claim-leukemia-stem-cell-signature-independently-predicts-poor-survival-in-aml/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Studies Show Natural Protein May Provide Benefits Against Stroke up to 12 Hours After Onset</title>
		<link>http://www.bioscreening.net/2011/07/27/studies-show-natural-protein-may-provide-benefits-against-stroke-up-to-12-hours-after-onset/</link>
		<comments>http://www.bioscreening.net/2011/07/27/studies-show-natural-protein-may-provide-benefits-against-stroke-up-to-12-hours-after-onset/#comments</comments>
		<pubDate>Wed, 27 Jul 2011 20:38:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1216</guid>
		<description><![CDATA[Scientists suggest that treating stoke patients with an endogenous immunomodulatory neuroprotectant protein, ?B-crystallin (Cryab), could help limit brain damage even if first administered 12 hours after the onset of stroke. Studies by a Stanford University School of Medicine team in a mouse model of stroke found that administering Cryab to animals 12 hours after stroke [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/27/studies-show-natural-protein-may-provide-benefits-against-stroke-up-to-12-hours-after-onset/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A deadly new reason to avoid deer ticks</title>
		<link>http://www.bioscreening.net/2011/07/11/a-deadly-new-reason-to-avoid-deer-ticks/</link>
		<comments>http://www.bioscreening.net/2011/07/11/a-deadly-new-reason-to-avoid-deer-ticks/#comments</comments>
		<pubDate>Mon, 11 Jul 2011 18:35:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1204</guid>
		<description><![CDATA[Move over, Lyme disease: Another tick-borne illness is on the rise in various parts of the country, and this one can kill. Known as babesiosis, the disease is caused by a microscopic parasite that attacks blood cells, causing flu-like symptoms that can make it difficult to accurately diagnose. Like Lyme disease, which is caused by [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/11/a-deadly-new-reason-to-avoid-deer-ticks/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Coffee buzz protects brain from Alzheimer&#8217;s</title>
		<link>http://www.bioscreening.net/2011/06/30/coffee-buzz-protects-brain-from-alzheimers/</link>
		<comments>http://www.bioscreening.net/2011/06/30/coffee-buzz-protects-brain-from-alzheimers/#comments</comments>
		<pubDate>Thu, 30 Jun 2011 15:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1190</guid>
		<description><![CDATA[For years we’ve been told that caffeinated coffee was bad for us. It’s unhealthy and addictive, doctors warned. But as vindication for all who stuck by their energizing elixir, a new study shows that guzzling caffeinated coffee may actually be good for our brains. In fact, it may help keep Alzheimer’s at bay. The study, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/30/coffee-buzz-protects-brain-from-alzheimers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemophilia Is Target of Therapy on Genome</title>
		<link>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/</link>
		<comments>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/#comments</comments>
		<pubDate>Mon, 27 Jun 2011 15:13:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1184</guid>
		<description><![CDATA[Researchers using a new technique for editing the genome of living cells have shown that they can cure hemophilia in mice, at least in principle, with a couple of injections that carry out the “cut” and “paste” operations needed to insert a corrective gene. This is the first time this genome-editing technique has succeeded in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genentech to Appeal to F.D.A. for Breast Cancer Drug</title>
		<link>http://www.bioscreening.net/2011/06/27/genentech-to-appeal-to-f-d-a-for-breast-cancer-drug/</link>
		<comments>http://www.bioscreening.net/2011/06/27/genentech-to-appeal-to-f-d-a-for-breast-cancer-drug/#comments</comments>
		<pubDate>Mon, 27 Jun 2011 15:10:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[FDA News]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1182</guid>
		<description><![CDATA[Genentech this week will step up its efforts to keep the drug Avastin available as a treatment for breast cancer, urging the Food and Drug Administration to give it one more chance to prove the medicine works. At a hearing on Tuesday and Wednesday in suburban Washington, Genentech will ask the F.D.A. to reconsider its [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/27/genentech-to-appeal-to-f-d-a-for-breast-cancer-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Experimental Type 1 diabetes vaccine fails during second step of trial</title>
		<link>http://www.bioscreening.net/2011/06/27/experimental-type-1-diabetes-vaccine-fails-during-second-step-of-trial/</link>
		<comments>http://www.bioscreening.net/2011/06/27/experimental-type-1-diabetes-vaccine-fails-during-second-step-of-trial/#comments</comments>
		<pubDate>Mon, 27 Jun 2011 15:07:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1180</guid>
		<description><![CDATA[The quest for a vaccine to stop Type 1 diabetes in its tracks has hit a roadblock. An experimental drug failed in the second step of a three-phase trial on 145 American and Canadian patients who had just been diagnosed with the disease. The vaccine is based on an enzyme that is targeted by a [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/27/experimental-type-1-diabetes-vaccine-fails-during-second-step-of-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kidney improvement sustained by Abbott drug-study</title>
		<link>http://www.bioscreening.net/2011/06/24/kidney-improvement-sustained-by-abbott-drug-study/</link>
		<comments>http://www.bioscreening.net/2011/06/24/kidney-improvement-sustained-by-abbott-drug-study/#comments</comments>
		<pubDate>Fri, 24 Jun 2011 15:18:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1177</guid>
		<description><![CDATA[NEW YORK, June 24 (Reuters) &#8211; Diabetics with moderate to severe chronic kidney disease showed significant and sustained improvement in kidney function through 52 weeks of treatment with a novel drug being developed by Abbott Laboratories (ABT.N), according to data from a midstage clinical trial. The oral drug, bardoxolone methyl, is the first medicine to [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/24/kidney-improvement-sustained-by-abbott-drug-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer&#8217;s Remoxy Fails to Win FDA Approval</title>
		<link>http://www.bioscreening.net/2011/06/24/pfizers-remoxy-fails-to-win-fda-approval/</link>
		<comments>http://www.bioscreening.net/2011/06/24/pfizers-remoxy-fails-to-win-fda-approval/#comments</comments>
		<pubDate>Fri, 24 Jun 2011 15:13:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[FDA News]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1175</guid>
		<description><![CDATA[WASHINGTON &#8212; The latest attempt at an abuse-resistant formulation of oxycodone (Remoxy) failed to win approval from the FDA, according to a statement from Pfizer. Late Thursday, the company said it had received a complete response letter from the FDA, which described the reasons for the FDA&#8217;s decision. The FDA had turned down an earlier [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/24/pfizers-remoxy-fails-to-win-fda-approval/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer, Acura Say FDA Clears Painkiller Oxecta</title>
		<link>http://www.bioscreening.net/2011/06/21/pfizer-acura-say-fda-clears-painkiller-oxecta/</link>
		<comments>http://www.bioscreening.net/2011/06/21/pfizer-acura-say-fda-clears-painkiller-oxecta/#comments</comments>
		<pubDate>Tue, 21 Jun 2011 15:02:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[FDA News]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1166</guid>
		<description><![CDATA[Pfizer Inc. and Acura Pharmaceuticals Inc. said Monday the Food and Drug Administration approved a powerful painkiller that is designed to be harder to abuse. The FDA cleared marketing of Oxecta as an immediate-release treatment for moderate to severe pain. The drug is designed to discourage common methods of abuse like crushing or dissolving, and [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/21/pfizer-acura-say-fda-clears-painkiller-oxecta/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

